Dexamethasone; Tobramycin Patent Expiration
Dexamethasone; Tobramycin is Used for treating ocular inflammation with infection or risk of infection using a combination of tobramycin and dexamethasone. It was first introduced by Sandoz Inc
Dexamethasone; Tobramycin Patents
Given below is the list of patents protecting Dexamethasone; Tobramycin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tobradex St | US7795316 | Topical ophthalmic compositions containing tobramycin and dexamethasone | Aug 03, 2028 | Harrow Eye |
| Tobradex St | US8101582 | Topical ophthalmic compositions containing tobramycin and dexamethasone | Dec 19, 2027 | Harrow Eye |
| Tobradex St | US8450287 | Topical ophthalmic compositions containing tobramycin and dexamethasone | Dec 19, 2027 | Harrow Eye |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Dexamethasone; Tobramycin's patents.
Latest Legal Activities on Dexamethasone; Tobramycin's Patents
Given below is the list recent legal activities going on the following patents of Dexamethasone; Tobramycin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 09 Jun, 2024 | US8450287 |
| Email Notification Critical
| 12 Dec, 2023 | US8450287 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 12 Dec, 2023 | US8101582 |
| Email Notification Critical
| 12 Dec, 2023 | US7795316 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 12 Dec, 2023 | US8450287 |
| Email Notification Critical
| 12 Dec, 2023 | US8101582 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 12 Dec, 2023 | US7795316 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 24 Jan, 2023 | US8101582 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 14 Sep, 2021 | US7795316 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 12 Aug, 2020 | US8450287 |
Dexamethasone; Tobramycin's Family Patents
